Fitusiran
Showing 1 - 6 of 6
Hemophilia A Trial (Fitusiran (SAR439774), Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin
Not yet recruiting
- Hemophilia A
- Fitusiran (SAR439774)
- +3 more
- (no location specified)
Nov 17, 2023
Hemophilia Trial in Orange (Fitusiran, Clotting factor concentrates (CFC) or bypassing agents (BPA), Antithrombin concentrate
Recruiting
- Hemophilia
- Fitusiran
- +2 more
-
Orange, CaliforniaCenter for Inherited Blood Disorders (CIBD)-Site Number:8400012
Feb 2, 2023
Hemophilia A, Hemophilia B Trial in Worldwide (Fitusiran (SAR439774))
Active, not recruiting
- Hemophilia A
- Hemophilia B
- Fitusiran (SAR439774)
-
Ann Arbor, Michigan
- +11 more
Aug 4, 2022
Hemophilia Trial in Worldwide (Fitusiran)
Completed
- Hemophilia
- Fitusiran
-
Little Rock, Arkansas
- +43 more
May 11, 2022
Hemophilia A, Hemophilia B Trial in Worldwide (fitusiran, factor concentrates)
Completed
- Hemophilia A
- Hemophilia B
- fitusiran
- factor concentrates
-
Little Rock, Arkansas
- +63 more
Mar 15, 2022
Hemophilia A, Hemophilia B Trial in Worldwide (fitusiran, Bypassing agents)
Completed
- Hemophilia A
- Hemophilia B
- fitusiran
- Bypassing agents
-
Phoenix, Arizona
- +57 more
Mar 15, 2022